14-104714406-G-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_022489.4(INF2):c.3244G>T(p.Ala1082Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00027 in 1,604,876 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_022489.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INF2 | NM_022489.4 | c.3244G>T | p.Ala1082Ser | missense_variant | 21/23 | ENST00000392634.9 | NP_071934.3 | |
INF2 | NM_001031714.4 | c.3244G>T | p.Ala1082Ser | missense_variant | 21/22 | NP_001026884.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INF2 | ENST00000392634.9 | c.3244G>T | p.Ala1082Ser | missense_variant | 21/23 | 5 | NM_022489.4 | ENSP00000376410 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00136 AC: 207AN: 152172Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000365 AC: 84AN: 230142Hom.: 1 AF XY: 0.000310 AC XY: 39AN XY: 125708
GnomAD4 exome AF: 0.000155 AC: 225AN: 1452586Hom.: 0 Cov.: 38 AF XY: 0.000140 AC XY: 101AN XY: 722008
GnomAD4 genome AF: 0.00137 AC: 209AN: 152290Hom.: 0 Cov.: 34 AF XY: 0.00120 AC XY: 89AN XY: 74462
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2023 | INF2: BP4, BS1 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 25, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Focal segmental glomerulosclerosis 5;C4302667:Charcot-Marie-Tooth disease dominant intermediate E Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at